460 related articles for article (PubMed ID: 1800586)
1. Conflict of interest and informed consent in industry-sponsored clinical trials.
Shimm DS; Spece RG
J Leg Med; 1991 Dec; 12(4):477-513. PubMed ID: 1800586
[No Abstract] [Full Text] [Related]
2. Human experimentation. Protecting patient autonomy through informed consent.
Tuthill KA
J Leg Med; 1997 Jun; 18(2):221-50. PubMed ID: 9230568
[No Abstract] [Full Text] [Related]
3. Informed consent in medical experimentation.
Burgess MM
Ann R Coll Physicians Surg Can; 1987 Jan; 20(1):29-31. PubMed ID: 11649817
[No Abstract] [Full Text] [Related]
4. Policies and quality assurance in the pharmaceutical industry.
Shamoo AE
Account Res; 1991; 1(4):273-84. PubMed ID: 11651459
[No Abstract] [Full Text] [Related]
5. The standard of disclosure in human subject experimentation.
Morin K
J Leg Med; 1998 Jun; 19(2):157-221. PubMed ID: 9658739
[No Abstract] [Full Text] [Related]
6. Is post-marketing drug follow-up research or advertising?
Weiss GB; Winslade WJ
IRB; 1987; 9(4):10-1. PubMed ID: 11649947
[No Abstract] [Full Text] [Related]
7. Research participation and financial inducements.
Resnik DB
Am J Bioeth; 2001; 1(2):54-6. PubMed ID: 11951894
[No Abstract] [Full Text] [Related]
8. Playing roulette with experimental drugs.
Budiansky S
US News World Rep; 1987 Jul; 103(2):58-9. PubMed ID: 11658841
[No Abstract] [Full Text] [Related]
9. Medical ethics. Principles for human gene therapy studies.
Friedmann T
Science; 2000 Mar; 287(5461):2163-5. PubMed ID: 10744537
[No Abstract] [Full Text] [Related]
10. Conflicts of interest in medical research: how much conflict should exceed legal boundaries?
Klanica K
J Biolaw Bus; 2005; 8(3):37-45. PubMed ID: 16459426
[TBL] [Abstract][Full Text] [Related]
11. Adequate protection for the autonomous research subject? The disclosure of sources of funding and commercialisation in genetic research trials.
Cote A
Manit Law J; 2002; 28(3):347-58. PubMed ID: 15162817
[No Abstract] [Full Text] [Related]
12. Why did Jesse die?
Walters J
Update; 2001 Nov; 17(2):E1. PubMed ID: 16130258
[No Abstract] [Full Text] [Related]
13. Research ethics.
Aarons D
West Indian Med J; 1995 Dec; 44(4):115-8. PubMed ID: 8838046
[TBL] [Abstract][Full Text] [Related]
14. Legal and ethical issues associated with patient recruitment in clinical trials: the case of competitive enrolment.
Caulfield T
Health Law Rev; 2005; 13(2-3):58-61. PubMed ID: 16459415
[No Abstract] [Full Text] [Related]
15. Ethics of volunteer research: the role of new EC guidelines.
Haynes WG; Webb DJ
Br J Clin Pharmacol; 1991 Dec; 32(6):671-6. PubMed ID: 1768558
[No Abstract] [Full Text] [Related]
16. Why I oppose drug company payment of physician/investigators on a per patient/subject basis.
Roizen R
IRB; 1988; 10(1):9-10. PubMed ID: 11658990
[No Abstract] [Full Text] [Related]
17. Ethical issues related to clinical pharmacy research. American College of Clinical Pharmacy.
Pharmacotherapy; 1993; 13(5):523-30. PubMed ID: 8247927
[No Abstract] [Full Text] [Related]
18. The perverse consequences of a proposed global tax on research.
MacDonald C; Walton N
Am J Bioeth; 2010 Jun; 10(6):46-7. PubMed ID: 20526972
[No Abstract] [Full Text] [Related]
19. The case for per patient payments.
Lewis JP
IRB; 1988; 10(5):9. PubMed ID: 11650075
[No Abstract] [Full Text] [Related]
20. A researcher's concern with ethics in human research.
Levine RH
J Calif Alliance Ment Ill; 1994; 5(1):6-8. PubMed ID: 11653328
[No Abstract] [Full Text] [Related]
[Next] [New Search]
